Does USTEKINUMAB Cause Osteoporosis? 669 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 669 reports of Osteoporosis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.8% of all adverse event reports for USTEKINUMAB.
669
Reports of Osteoporosis with USTEKINUMAB
0.8%
of all USTEKINUMAB reports
357
Deaths
290
Hospitalizations
How Dangerous Is Osteoporosis From USTEKINUMAB?
Of the 669 reports, 357 (53.4%) resulted in death, 290 (43.3%) required hospitalization, and 248 (37.1%) were considered life-threatening.
Is Osteoporosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 669 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Osteoporosis?
EMTRICITABINE\TENOFOVIR DISOPROXIL (7,436)
TENOFOVIR DISOPROXIL (5,302)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,029)
ADALIMUMAB (2,665)
PREDNISONE (2,476)
METHOTREXATE (2,018)
ETANERCEPT (1,766)
COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,720)
TOCILIZUMAB (1,689)
ALENDRONATE (1,688)
Which USTEKINUMAB Alternatives Have Lower Osteoporosis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE